Left Ventricular Assist Device Outflow Graft Obstruction: A Complication Specific to Polytetrafluoroethylene Covering. A Word of Caution!


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 24 12 2018
medline: 28 5 2020
entrez: 22 12 2018
Statut: ppublish

Résumé

Pump thrombosis is an established complication of left ventricular assist devices (LVADs). Outflow graft obstruction has been previously described as one cause of LVAD thrombosis. We identified four cases of outflow graft obstruction that were attributed to a commonly applied polytetrafluoroethylene (PTFE) covering of the outflow graft. In this set of patients, the outflow graft was obstructed by a thrombus which formed between the outflow graft and its external PTFE covering, leading to impingement of the outflow graft. Patients typically presented after a median duration of 26 months (range 23-41 months) of support with gradual increase of heart failure symptoms and low pump flows. Computed tomography angiography was found to be the best diagnostic modality. Treatments included surgical LVAD replacement as well as percutaneous intraluminal stenting of the outflow graft. Our findings indicate that PTFE graft covering of the LVAD outflow graft can lead to graft occlusion and should be reconsidered as a potentially harmful modification to the approved device implant technique.

Identifiants

pubmed: 30575627
doi: 10.1097/MAT.0000000000000929
doi:

Substances chimiques

Polytetrafluoroethylene 9002-84-0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e58-e62

Auteurs

Talal Alnabelsi (T)

From the Department of Internal Medicine, Division of Cardiovascular Diseases, University of Kentucky, Lexington, Kentucky.

Alexis E Shafii (AE)

Department of Surgery, Division of Transplantation, University of Kentucky, Lexington, Kentucky.

John C Gurley (JC)

From the Department of Internal Medicine, Division of Cardiovascular Diseases, University of Kentucky, Lexington, Kentucky.

Kenneth Dulnuan (K)

From the Department of Internal Medicine, Division of Cardiovascular Diseases, University of Kentucky, Lexington, Kentucky.

Dwight D Harris (DD)

University of Kentucky College of Medicine, University of Kentucky, Lexington, Kentucky.

Maya Guglin (M)

Department of Surgery, Division of Transplantation, University of Kentucky, Lexington, Kentucky.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH